Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India
Conditions: Pre-Extensively Drug-Resistant Pulmonary TB; Treatment Intolerant Multidrug-Resistant Pulmonary TB; Non-responsive Multidrug-Resistant Pulmonary TB Interventions: Drug: Linezolid; Drug: Bedaquiline; Drug: Pretomanid Sponsors: Tuberculosis Research Centre, India; International Union Against Tuberculosis and Lung Diseases; Sarvodaya Charitable Trust Hospital, Ghatkopar, Mumbai; Shatabdi Centenary Hospital, Govandi, Mumbai; KGMU, Lucknow; SN Medical College, Agra; BJ Medical College, Ahme dabad; Govt. Medical College, Surat; NITRD, New Delhi; RBIPMT, Delhi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bedaquiline | Hospitals | India Health | Linezolid | Multidrug Resistance | Research | Tuberculosis | Zyvox